VMD-102A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Sponsor:

VM Discovery, Inc.

Code:

NCT07636785

Conditions

Hepatocellular Carcinoma (HCC)

Metastatic Uveal Melanoma

Renal Cell Carcinoma (RCC)

Nonsmall Cell Lung Cancer

Colorectal Cancer (CRC)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

VMD-102

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by VM Discovery, Inc. on 2026-08-19.